| Dr Brandon James Hawkins, DPM | |
|
110 New Stine Rd, Bakersfield, CA 93309 | |
| (661) 832-1667 | |
| (661) 832-7145 |
| Full Name | Dr Brandon James Hawkins |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 23 Years |
| Location | 110 New Stine Rd, Bakersfield, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073587663 | NPI | - | NPPES |
| E4648 | Other | CA | LIC: |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | E4648 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Health Bakersfield | Bakersfield, CA | Hospital |
| Mercy Hospital | Bakersfield, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Stockdale Podiatry Group Inc | 0143282715 | 12 |
News Archive
The Michael J. Fox Foundation for Parkinson's Research is teaming up with EHE International to raise awareness of the fight against Parkinson's disease. For the month of July, EHE International has kindly donated a 115-square-foot window space at 10 Rockefeller Plaza to showcase the many ways ordinary citizens can support the Foundation through its grassroots fundraising arm, Team Fox.
Prosensa, the Dutch biopharmaceutical company focusing on RNA modulating therapeutics, has announced that it received a £7.5m milestone payment from GlaxoSmithKline (GSK) as a result of achieving a data milestone in its Phase IIa open label extension trial of GSK2402968 (PRO051), being developed to treat Duchenne Muscular Dystrophy (DMD) under its agreement with GSK. The milestone payment was based upon achievement of a successful safety review, with no serious safety signals observed.
Neurologic outcomes for survivors of out-of-hospital cardiac arrest are significantly improved after implementation of the 2010 American Heart Association's fifth link in the chain-of-survival concept for postresuscitation care, show Japanese study results.
Resverlogix Corp. announces that the Company's Phase 2 clinical trial, called ASSURE (ApoA-1 Synthesis Stimulation in Acute Coronary Syndrome patients), has made important modifications to the design of the trial which have the potential to demonstrate a more powerful endpoint for the planning of future clinical trials for RVX-208.
› Verified 8 days ago
| Provider Name | Stockdale Podiatry Group Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1013013002 PECOS PAC ID: 0143282715 Enrollment ID: O20041027000646 |
News Archive
The Michael J. Fox Foundation for Parkinson's Research is teaming up with EHE International to raise awareness of the fight against Parkinson's disease. For the month of July, EHE International has kindly donated a 115-square-foot window space at 10 Rockefeller Plaza to showcase the many ways ordinary citizens can support the Foundation through its grassroots fundraising arm, Team Fox.
Prosensa, the Dutch biopharmaceutical company focusing on RNA modulating therapeutics, has announced that it received a £7.5m milestone payment from GlaxoSmithKline (GSK) as a result of achieving a data milestone in its Phase IIa open label extension trial of GSK2402968 (PRO051), being developed to treat Duchenne Muscular Dystrophy (DMD) under its agreement with GSK. The milestone payment was based upon achievement of a successful safety review, with no serious safety signals observed.
Neurologic outcomes for survivors of out-of-hospital cardiac arrest are significantly improved after implementation of the 2010 American Heart Association's fifth link in the chain-of-survival concept for postresuscitation care, show Japanese study results.
Resverlogix Corp. announces that the Company's Phase 2 clinical trial, called ASSURE (ApoA-1 Synthesis Stimulation in Acute Coronary Syndrome patients), has made important modifications to the design of the trial which have the potential to demonstrate a more powerful endpoint for the planning of future clinical trials for RVX-208.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Brandon James Hawkins, DPM 110 New Stine Rd, Bakersfield, CA 93309-2605 Ph: (661) 832-1667 | Dr Brandon James Hawkins, DPM 110 New Stine Rd, Bakersfield, CA 93309 Ph: (661) 832-1667 |
News Archive
The Michael J. Fox Foundation for Parkinson's Research is teaming up with EHE International to raise awareness of the fight against Parkinson's disease. For the month of July, EHE International has kindly donated a 115-square-foot window space at 10 Rockefeller Plaza to showcase the many ways ordinary citizens can support the Foundation through its grassroots fundraising arm, Team Fox.
Prosensa, the Dutch biopharmaceutical company focusing on RNA modulating therapeutics, has announced that it received a £7.5m milestone payment from GlaxoSmithKline (GSK) as a result of achieving a data milestone in its Phase IIa open label extension trial of GSK2402968 (PRO051), being developed to treat Duchenne Muscular Dystrophy (DMD) under its agreement with GSK. The milestone payment was based upon achievement of a successful safety review, with no serious safety signals observed.
Neurologic outcomes for survivors of out-of-hospital cardiac arrest are significantly improved after implementation of the 2010 American Heart Association's fifth link in the chain-of-survival concept for postresuscitation care, show Japanese study results.
Resverlogix Corp. announces that the Company's Phase 2 clinical trial, called ASSURE (ApoA-1 Synthesis Stimulation in Acute Coronary Syndrome patients), has made important modifications to the design of the trial which have the potential to demonstrate a more powerful endpoint for the planning of future clinical trials for RVX-208.
› Verified 8 days ago
Stockdale Podiatry Group Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 110 New Stine Rd, Bakersfield, CA 93309 Phone: 661-832-1666 Fax: 661-832-2039 | |
Thomas D Nelson Dpm Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1701 27th St, Bakersfield, CA 93301 Phone: 661-322-2895 Fax: 661-322-2897 | |
Dr. James Francis Brown, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 110 New Stine Rd, Bakersfield, CA 93309 Phone: 661-832-1667 Fax: 661-832-7145 | |
Dr. Allan Evangelista, D.P.M., M.P.H. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 110 New Stine Rd, Bakersfield, CA 93309 Phone: 661-832-1667 Fax: 661-832-7145 | |
Ali Ghorbanifarajzadeh, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 500 Old River Rd Ste 185, Bakersfield, CA 93311 Phone: 661-832-3600 Fax: 661-322-6249 | |
Carlos J. Rodriguez, DPM, MS, PA Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 5020 Commerce Dr, Bakersfield, CA 93309 Phone: 661-324-4100 Fax: 661-324-4600 |